![logo](/logos/ORX.ST.webp)
Orexo AB (publ)
SSE:ORX.ST
14.5 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Orexo AB (publ) |
Symbool | ORX.ST |
Munteenheid | SEK |
Prijs | 14.5 |
Beurswaarde | 498,329,867 |
Dividendpercentage | 0% |
52-weken bereik | 8.44 - 20.1 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Nikolaj Sorensen |
Website | https://www.orexo.com |
An error occurred while fetching data.
Over Orexo AB (publ)
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)